Our Approach To Non-Small Cell Lung Cancer

Find a Doctor Find a Clinical Trial Or Call Us: 646-929-7950

What Sets Us Apart

Non-small cell lung cancer is the most common type of cancer affecting the lungs. At NYU Langone’s Laura and Isaac Perlmutter Cancer Center, our doctors encourage people at high risk to participate in our Lung Cancer Screening Program. Our goal at NYU Langone is to detect lung cancer early, when treatment is most effective. 

If lung cancer is suspected, our imaging specialists and cytopathologists, doctors who study diseases at the cellular level, can ensure an accurate diagnosis, which may involve tissue testing to analyze the tumor’s genetic makeup. After diagnosis, our pulmonologists, thoracic surgeons, medical oncologists, radiation oncologists, and interventional radiologists create a customized treatment plan for you.


At NYU Langone’s Perlmutter Cancer Center, a National Cancer Institute-designated cancer center, we personalize the care of every patient.More About Perlmutter Cancer Center

CLINICAL TRIALS and Research Studies

Our teams of physicians and scientists work together across multiple disciplines to bring our patients the most innovative clinical trials.Find a Clinical Trial

Our clinical trials can provide the newest therapeutic options. We also offer many supportive services, such as lung rehabilitation, psychological care, and integrative health therapies.

Treatment at NYU Langone

There are many ways to manage non-small cell lung cancer, which may include surgery, radiation therapy, chemotherapy and targeted medications, ablative therapies, and endobronchial stenting.

Related News

More Resources

Meet Our Doctors

NYU Langone specialists provide care and support throughout your entire healthcare journey.

Browse Doctors